ea0081ep573 | Endocrine-Related Cancer | ECE2022
Olearska Helena
, Sowa-Staszczak Anna
, Opalinska Marta
, Kurzyńska Anna
, Hubalewska-Dydejczyk Alicja
Introduction: Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group with various treatment options depending on grading, staging, and presence of symptoms related to hormonal secretion. Their incidence significantly increased over the past decade and nowadays constitutes 30% of all NETs of the gastrointestinal tract. Despite the evidence of a different malignancy potential of PNETs G2, postoperative management is the same in all patients. Ai...